NEW YORK (GenomeWeb) – In competing notes to investors today, analysts at Evercore ISI and Piper Jaffray have issued new opinions on Hologic, with Evercore downgrading the company to Hold from Buy, and Piper Jaffray upgrading it to Overweight from Neutral.

The banks also changed their price targets for Hologic. Evercore lowered its target to $42 while Piper Jaffray raised its to $48.

To read the full story....

Register for Free.

Already have a GenomeWeb or 360Dx account?
Login Now.

Berkeley researchers have engineered yeast to make the molecule behind the hoppy taste of beer, Quartz reports.

King's College London researchers examine the influence of school type and genetics on academic achievement.

FiveThirtyEight writes that most who take a direct-to-consumer BRCA1/2 genetic test won't learn much from it.

In Science this week: early life experience influence somatic variation in the genome, and more.